Warning lights
Signals from the annual accounts, the CBE and the Official Gazette, each with its threshold and source. No score, no verdict.
-
Negative equity NBB
More debt than assets in 1 of the last 3 fiscal years.
-
Two loss years in a row NBB
Negative result in 2024 and 2025.
-
Not on Peppol Peppol
Not registered in the Peppol network, mandatory for VAT-liable companies since 1 January 2026.
Financials
Financial year 2025
ENDODIABETO from Liège, company number BE0793117629, closed financial year 2025 with a result of € -5,044 after tax. For that financial year ENDODIABETO recorded a gross margin of € -4,491 and equity of € -4,590. Compared with financial year 2024, the result moved from € -964 to € -5,044. The company made a loss. More debts than assets. High debts against a small own buffer. The most recent annual accounts were filed with the National Bank of Belgium on June 30, 2026.
€ -4,590
▼ € 5,044 vs 2024
Assets minus debts, by the books. What is left if everything were sold and paid today.
€ -5,044
▼ 423 % more loss than in 2024
Profit after tax over the fiscal year.
€ 10,786
▼ 7% vs 2024
Cash and bank balances on the last day of the fiscal year.
Loss, nothing to pay out
Reserves fell to € -9,590.
Debts at end 2025
None
No bank loans on the last day of the fiscal year.
€ 5,646
▲ 16% vs 2024
Supplier invoices still open on the last day of the fiscal year.
Want to see how much further we take a dossier in the Pro version? Open the free De Lijn example and give feedback →
| 2023 | 2024 | 2025 | Change 2024 → 2025 | |
|---|---|---|---|---|
| Gross margin | € -2,719 | € -437 | € -4,491 | ▼ € 4,054 |
| Profit after taxes | € -3,582 | € -964 | € -5,044 | ▼ € 4,080 |
| Equity | € 1,418 | € 454 | € -4,590 | ▼ € 5,044 |
| Total debts | € 148,869 | € 169,619 | € 204,712 | ▲ 21% |
| Cash | € 1,222 | € 11,646 | € 10,786 | ▼ 7% |
| Retained profit | € -3,582 | € -4,546 | € -9,590 | ▼ € 5,044 |
| Balance sheet total | € 150,287 | € 170,073 | € 200,122 | ▲ 18% |
Key figures of ENDODIABETO, fiscal years 2023 to 2025, from the annual accounts filed with the National Bank of Belgium.Next annual account (fiscal year 2026) expected before 31 July 2027.
What happened to ENDODIABETO?
What happened at ENDODIABETO in recent years, according to the Belgian Official Gazette, the CBE and the National Bank:
- New annual accounts for financial year 2025: loss of € 5,044. Source: NBB ↗
- New establishment in Liège. KBO
- ISABELLE GERONOOZ became a director. NBB
- CYRINE DEMNATI became a director. NBB
- Start of the company according to the CBE. KBO
In short
From € 3,582 loss in 2023 to € 5,044 loss in 2025.
A new publication or filing at ENDODIABETO? We notify you, reason included.
Follow ENDODIABETODatabakkes Pro
Know what changes at your customers, suppliers and competitors. Without reading an annual account.
- Follow them in one folder Every company in your folder gets this full dossier: household book, all fiscal years, benchmark against companies of the same size.
- We alert you, with the reason New annual account, Official Gazette publication or status change: you get what changed and where it says so.
- In bulk too, and in ChatGPT and Claude Upload your customer list and get the warning signs back per company. Or ask in your own AI assistant, with this register as the source.
Databakkes Pro is being built. Sign up now and you are first in line for an invitation, with a month to try without a credit card.
De Lijn 8 June 2026 New annual account 2025
filed on 8 June 2026
What was left
€ 20 k ▼ 91%
Money in the bank
€ 178 k ▼ 98%
Open the dossier →
NMBS 8 June 2026 New annual account 2025 What was left ▼ 80%
bpost 18 May 2026 New annual account 2025 What was left from loss to profit
Management
Behind ENDODIABETO are ISABELLE GERONOOZ and CYRINE DEMNATI.
Directors
According to the 2025 annual accounts
ISABELLE GERONOOZ
Director
since 2022
CYRINE DEMNATI
Director
since 2022
Establishments
Establishment units
Physical locations of this company
Rue du Pressoir 43
4000 Liège
Who else lives here?
A building full of entrepreneurs or one very busy letterbox? Another 9 companies are registered at this address.
All companies at this address →PMI POOL MEDECINE INTERNE
€ 14,567 gross margin · 2025
FIDUCIAIRE LIEGEOISE
€ 192,819 gross margin · 2025
POOL ANESTHESIOLOGIE - REANIMATION
€ 10,943 gross margin · 2025
Alarm Hesbaye
RespiVerviers
€ 2,662 gross margin · 2025
+4 more
What is an establishment unit? An establishment unit is a geographically identifiable place where activities of the enterprise are carried out.
Details
- Company number
- 0793.117.629
- VAT number
- BE 0793.117.629
- Registered office
- Rue du Pressoir 43, 4000 Liège
- Names & denominations
- ENDODIABETO
- Enterprise type
- Rechtspersoon
- Legal form
- Private limited company
- Legal situation
- Normale toestand
- Start date
- 28 October 2022
- Peppol
- Not registered